Medical Device Market Entry South Africa

Published: 22 June 2023
Last updated: 8 October 2026

Entering the South African medical device market involves more than appointing a sales distributor and arranging the first shipment.

Foreign manufacturers need to establish a regulatory route that addresses device classification, South African establishment licensing, local regulatory responsibility, product listing, quality management, technical documentation, importation and post-market obligations.

The South African Health Products Regulatory Authority, or SAHPRA, regulates medical devices and in vitro diagnostic medical devices, or IVDs, under the Medicines and Related Substances Act and the Regulations Relating to Medical Devices and In Vitro Diagnostic Medical Devices.

A foreign manufacturer does not necessarily need to establish its own South African importing company. A South African establishment holding the appropriate distributor licence can import and distribute devices under a suitable regulatory and commercial arrangement. However, the entity responsible for regulated activities must hold the correct SAHPRA medical device establishment licence.

South Africa’s product registration system is also continuing to develop. Foreign manufacturers therefore need to address both current compliance requirements and preparation for the developing registration framework.

How does a foreign medical device manufacturer enter South Africa?

A foreign manufacturer should approach South African market entry as a sequence of connected regulatory decisions.

The manufacturer needs to confirm the regulatory status and classification of the product, determine who will import and distribute it, establish the appropriate SAHPRA licensing structure, appoint an Authorised Representative, prepare product information and quality documentation, and establish compliant import and post-market processes.

These activities should be planned together.

A commercial distributor should not be appointed without confirming whether its licence and quality system support the proposed activities. Similarly, products should not be shipped merely because they already carry CE marking, FDA clearance or another foreign approval.

For the broader regulatory framework, see Medical Devices and IVDs in South Africa: The Regulatory Framework Explained.

Step 1: Confirm that the product is a medical device or IVD

The first step is to confirm whether the product meets the South African definition of a medical device or IVD.

Borderline products such as software, laboratory products, accessories, wellness products and combination products may require closer regulatory assessment.

The manufacturer’s intended purpose is particularly important and should remain consistent across the instructions for use, labelling, technical documentation, website and promotional claims.

Step 2: Determine the South African risk classification

South Africa classifies medical devices and IVDs into Classes A, B, C and D.

Manufacturers should not simply transfer a foreign classification into the South African application.

SAHPRA’s classification guidance specifically recognises that a device may have a different classification in South Africa from the classification assigned in another jurisdiction.

See Medical Device Classification in South Africa: Classes A, B, C and D or Verion Medical’s medical device classification service.

Step 3: Choose the South African market-entry structure

The foreign manufacturer needs to determine which entity will perform regulated activities in South Africa.

Common approaches include establishing a South African entity, appointing a licensed local distributor or using an appropriate combination of a licensed distributor and third-party logistics providers.

The regulatory model should be selected together with the commercial strategy rather than after contracts have already been signed.

Establishing your own South African operation

A foreign manufacturer may establish a South African operation and obtain the appropriate medical device establishment licence.

Where the entity imports and distributes finished devices, the distributor pathway is generally relevant.

If the entity performs activities considered manufacturing, including certain packaging, labelling, assembly, servicing or refurbishment activities, the manufacturer licensing pathway may apply.

A manufacturer licence can also encompass import, distribution and export activities.

See SAHPRA Medical Device Establishment Licence: Complete Guide.

Appointing a South African distributor

Many international manufacturers enter South Africa by appointing a licensed local distributor.

A distributor licence permits the relevant establishment to import, export and distribute medical devices and IVDs.

Before appointment, manufacturers should review the distributor’s licence, approved activities, quality system, product scope, storage arrangements, post-market processes and regulatory capabilities.

The distribution agreement should also define regulatory responsibilities rather than dealing only with sales, pricing and territory.

Why a wholesaler cannot act as the importer

A South African wholesaler and distributor are not the same regulatory entity.

A wholesaler generally procures products from a local manufacturer or distributor and supplies them onward.

A wholesaler licence does not independently authorise importation or exportation.

Foreign manufacturers intending to ship directly to a South African partner should therefore verify that the partner holds the appropriate distributor licence rather than relying on its commercial description.

See Medical Device Wholesale Licence in South Africa: SAHPRA Requirements.

Step 4: Establish the Authorised Representative arrangement

A medical device establishment requires an Authorised Representative.

The Authorised Representative is a natural person resident in South Africa who has a written mandate to represent the relevant establishment and carries regulatory responsibilities relating to medical devices or IVDs.

The role should be established early because it is tied to the licence holder’s regulatory and quality responsibilities.

See SAHPRA Authorised Representative: Requirements and Responsibilities.

Step 5: Obtain the appropriate SAHPRA establishment licence

SAHPRA recognises manufacturer, distributor and wholesaler medical device establishment licences.

The licence type should reflect the activities actually performed at the establishment.

Verion Medical provides SAHPRA medical device establishment licensing support for organisations developing or changing their South African regulatory structure.

Step 6: Prepare the South African product listing

The establishment licence process includes product information relating to the medical devices or IVDs handled by the establishment.

The product listing should include accurate classification, product or family information, GMDN information where applicable and relevant manufacturer details.

The list should be treated as a regulatory record rather than merely a commercial catalogue.

Foreign approvals and regulatory evidence

Foreign regulatory approvals can be important evidence within the South African regulatory pathway.

Manufacturers should retain applicable marketing authorisations, CE certificates, FDA clearances or approvals, ISO 13485 certification, declarations of conformity, technical documentation, labels and post-market information.

Higher-risk products may require evidence demonstrating prior regulatory approval and supporting technical information.

These documents are also increasingly important as SAHPRA develops reliance-based review pathways.

Step 7: Address ISO 13485 and QMS requirements

A compliant South African establishment requires an appropriate Quality Management System.

For manufacturers and distributors, ISO 13485 has become increasingly important within SAHPRA’s licensing framework.

The foreign manufacturer’s global QMS and the South African establishment’s QMS should clearly define responsibilities for product changes, complaints, recalls, regulatory communication and technical documentation.

See ISO 13485 in South Africa: Requirements for Medical Device Companies or Verion Medical’s ISO 13485 and Quality Management Systems services.

Step 8: Review technical documentation and labelling

The manufacturer should review its technical documentation for compatibility with the South African regulatory pathway.

Relevant documentation can include intended purpose, classification rationale, risk management, clinical or performance evidence, verification and validation, software documentation, sterilisation information, shelf-life evidence, labels and instructions for use.

Verion Medical provides technical documentation and labelling support for devices intended for the South African market.

Step 9: Prepare the import and distribution model

Before the first commercial shipment, the parties should determine who will act as importer, where stock will be received and stored, who will control product records and how distribution requirements will be maintained.

Complaint handling, returns, traceability and recall responsibilities should also be established before commercial supply begins.

Verion Medical’s import and export services support the regulatory and operational preparation associated with medical device shipments.

Outsourced warehousing and third-party logistics

Outsourcing warehousing does not remove regulatory responsibility.

Medical device establishments using third parties for regulated activities need to ensure that the service provider has the appropriate regulatory status where required and that responsibilities are controlled through suitable agreements and quality processes.

Storage, traceability, temperature control, complaints and recalls should all be addressed within the outsourced model.

What about medical device product registration?

South African legislation provides for medical device registration, while SAHPRA continues to develop and implement the broader operational registration framework.

SAHPRA has indicated that devices will be called up progressively according to a Registration Call-Up Plan.

The Medical Devices Registration Feasibility Study has also been used to test and refine a comprehensive risk-based registration model.

International manufacturers should therefore maintain registration-ready documentation even where their current route to market is based primarily on establishment licensing and product listing.

See Medical Device Registration in South Africa: SAHPRA Requirements.

SAHPRA reliance and foreign regulatory approvals

SAHPRA introduced a dedicated Medical Devices Reliance Guideline in 2026.

Reliance enables SAHPRA to take regulatory work performed by trusted authorities or institutions into account when making South African decisions.

The framework can apply to establishment licensing, product registration, ISO 13485 audits, clinical investigations and post-market regulatory activities.

Reliance does not mean automatic South African approval, but it increases the strategic value of well-organised foreign regulatory evidence.

See SAHPRA Medical Device Reliance Pathway: What Manufacturers Need to Know.

Post-market responsibilities after launch

The foreign manufacturer and South African establishment should maintain processes covering complaints, adverse events, recalls, field corrective actions, product changes, safety information and regulatory correspondence.

The parties should clearly define how information moves between the manufacturer’s global regulatory team and the South African licence holder.

Market entry is therefore an ongoing compliance relationship rather than a once-off licence application.

Common market-entry mistakes

Common mistakes include appointing an unverified distributor, assuming a wholesaler can import, copying a foreign classification, treating CE marking or FDA approval as automatic SAHPRA approval and failing to establish an effective Authorised Representative arrangement.

Other weaknesses include inadequate QMS preparation, unsuitable third-party warehousing, shipping products before the product listing is ready, insufficient access to technical documentation and unclear post-market responsibilities.

A strong market-entry strategy should connect regulatory, quality, logistics and commercial planning.

A practical South African market-entry sequence

Begin with a regulatory gap assessment.

Confirm the product status and South African classification.

Review international approvals and technical documentation.

Select the South African importer and distribution model.

Confirm the Authorised Representative and establishment licence requirements.

Prepare the product listing and QMS.

Review technical documentation and labelling.

Establish the import, storage and distribution structure.

Define responsibilities between the foreign manufacturer, South African licence holder and outsourced providers.

Finally, maintain documentation suitable for both current requirements and the developing product-registration and reliance frameworks.

Key regulatory references

How Verion Medical supports international manufacturers entering South Africa

Verion Medical supports international medical device and IVD manufacturers in building a compliant route into the South African market.

Our medical device regulatory affairs services can support market-entry assessments, regulatory pathway development, classification and coordination of South African regulatory requirements.

Where local licensing is required, Verion Medical provides SAHPRA establishment licensing support, including licence pathway assessment, product-list preparation and regulatory readiness.

Our broader support includes medical device registration, device classification, technical documentation and labelling, ISO 13485 and Quality Management Systems, import and export support and market development.

The objective is to connect regulatory approval, quality readiness, importation and market access rather than treating each activity as a separate project.

If your organisation is considering South Africa as a new market for a medical device or IVD, contact Verion Medical to assess the regulatory and market-entry pathway before appointing distributors or arranging the first shipment.